Some patients also experience temporary nausea or constipation during dose increases, but these effects usually fade within a few days to a week
The estimated treatment difference (ETD) was -0.66 percent, with a 95 percent confidence interval of -0.76 to -0.57, and a p-value of less than 0.0001
And thats why theyre coming up with these new tricks. The FDA has allowed compounded GLP-1s to proliferate across the country
Additionally, long-term data on its effectiveness are limited compared to other procedures
Not for use in food, drug, or cosmetic applications
People who received semaglutide injections during clinical trials achieved a 5.9% weight loss percentage at 3 months and 10.9% at 6 months.* After 6 months, there were reports of individuals with higher BMIs (body mass index) losing 20-30% of their body weight